Food And Drug Administration-Magic Bullet-Pills-FDA

The FDA has approved two new weight-loss pills in less than a month. Are either...

The FDA has approved two new weight-loss Pills in less than a month. Are either of these new pills a magic bullet for dieters—or even a helpful weapon to add to their fat-fighting arsenal?
We take a look: http://bit.ly/MqJvHI
Are the New Weight-Loss Pills the Solution?
blog.womenshealthmag.com
After a 13-year dry spell, the Federal Food And Drug Administration (FDA) has approved two new weight-loss pills read more..

Food And Drug Administration-Overuse Of Antibiotics-Federal Court-Court Filings

FDA urged to rethink on antibiotics in animal feed

(Reuters) - A federal judge asked the Food And Drug Administration (FDA) to reexamine its decision to reject citizen calls to restrict the use of antibiotics in animal feed, court filings showed. The latest ruling is the second such setback for the FDA over concerns that overuse of antibiotics in animal feed is endangering human health by creating antibiotic-resistant "superbugs". In March, a federal court ordered the FDA to begin proceedings to withdraw approval for the use of penicillin and tetracyclines in animal feed unless makers of the drugs can produce evidence that their use is safe. ... read more..

source:http://yhoo.it/L5qiJt

Food And Drug Administration-Pre-Approval-Drugs-FDA

FDA says focused on tracking drugs after approval

Woodcock, Director of the Center for Drug Evaluation and Research at FDA, speaks during the Reuters Health Summit in New York

ATLANTA (Reuters) - The U.S. Food and Drug Administration said on Saturday it now spends as much effort and resources on surveilling a drug after it is approved as it does in the pre-approval process. The FDA was responding to critics who say the agency is toothless when it comes to tracking the safety of drugs already on the market, when industry funds that supported pre-approval reviews tend to dry up. "We think we've really balanced this," Dr. ... read more..

source:http://yhoo.it/I1pqXo

Antipsychotic Seroquel-Generic Versions-Administration-Market Entry-Astrazeneca

AstraZeneca sues FDA over generic Seroquel

A worker leaves the AstraZeneca research facility in Loughborough

LONDON (Reuters) - AstraZeneca said on Tuesday it was suing the Food and Administration after the U.S. regulator refused to delay the market entry later this month of generic versions of top-selling antipsychotic Seroquel. The drugmaker is seeking an injunction barring the FDA from granting final marketing approval of generic forms of the drug, whose chemical name is quetiapine, until December 2, 2012, or at least until a federal court has a chance to review the agency's action. ... read more..

source:http://yhoo.it/xVNt0Q